Sun-sensitizing drugs are drugs that have __________________ when people taking them are ________________ to the sun. Some reactions are caused by exposure to the sun's UVB or "___________" waves, but most are caused by UVA or "_____________" wave exposure. There are ____ main types of sun-sensitizing drug ______________. They are: __________allergy. In this case, problems occur when skin is exposed to the sun after certain medicines or compounds are _____________ to the skin's ____________. The ultraviolet (UV) light of the sun causes a ________________ change in the drug. This, in turn, causes the production of _______bodies that are responsible for the sun-sensitivity reaction. The reaction usually includes an eczema-type __________, which often occurs a _______ days after exposure. The rash can also ______________ to parts of the body that were ________ exposed to the sun. _________toxicity. This is the most _____________ type of sun-sensitivity drug reaction. It can occur when skin is exposed to the sun after certain medications are _____________, taken orally, or _____________ to the skin. The drug ____________ the UV light, then releases it into the skin, causing cell __________. Within a _______ days, symptoms appear on the ___________ areas of the body. In some people, symptoms can persist up to ____ years after the medication is ____________. Among the most _______________ phototoxic drugs are the tetracycline family, NSAIDs (nonsteroidal anti-inflammatory drugs such as ibuprofen), and amiodarone (Cordarone, a heart medication). It's important to note that _______________ person who uses these drugs has a _____________. If it does happen, it can be a _____-time occurrence, or it can happen _________ time the drug is taken and sun exposure occurs. People with HIV are among the ___________ likely group to experience sun sensitivity to drugs. Sun-sensitizing drugs can aggravate existing skin conditions, including eczema and herpes, and may inflame _________ tissue. Sun exposure can also _____________ or even precipitate autoimmune disorders, such as lupus. Can sunscreen help? Absolutely. It will _____________ the impact of sun exposure. But some ingredients in sunscreens are potentially photosensitizing, so in rare circumstances, it could _____________ symptoms. Ask the pharmacist about this. Drugs that can Cause Sun Sensitivity
There are lots of medications and over-the-counter drugs that can cause sun sensitivity. If you’re on prescription medication(s) and don’t see your drug listed below, please check with your pharmacist. Some of the most ______________ medications that are affected by you being in the sun include:
Antibiotics: Doxycycline, tetracycline, ciprofloxacin, ofloxacin, levofloxacin, trimethoprim
Antidepressants: doxepin (Sinequan); and other tricyclics; St. John's wort
Antihistamine: promethazine, diphenhydramine
Nonsteroidal anti-inflammatories: ibuprofen, ketoprofen, naproxen, celecoxib, Piroxicam
Diuretics: urosemide, bumetanide, hydrolorothiazide
Antihypertensives (blood pressure drugs): Aldactazide, Capozide, Cardizem, diltiazem
Cholesterol drugs: simvastatin, atorvastatin, lovastatin
PDT Pro photosensitizers: 5-aminolevulinic acid, methyl-5-aminolevulinic acid
Neuroleptic drugs: Chlorpromazine, fluphenazine, perphenazine, thioridazine, thiothixene
Sulfonamides: sulfadiazine, sulfamethoxazole, sulfasalazine, sulfisoxazole
Other drugs: Para-aminobenzoic acid (PABA), 5-FU, quinidine, dapsone
FOR IMMEDIATE RELEASE: May 19, 2008 CONTACT: Sarah Fait, (202) 778-8439, sfait@zuckerman.com ZUCKERMAN SPAEDER WINS FIRST CASE TESTING GENERIC EXCLUSIVITY FORFEITURE RULES Washington, D.C.— May 19, 2008 — Zuckerman Spaeder LLP client Roxane Laboratories, Inc. secured an important victory in the first case testing the generic exclusivity forfeiture provisions of the Federal F
Thorax 2000; 55 :375–382 EVect of one year treatment with inhaledfluticasone propionate or beclomethasonedipropionate on bone density and bonemetabolism: a randomised parallel group study inadult asthmatic subjectsT C Medici, E Grebski, M Häcki, P Rüegsegger, C Maden, J Efthimiou, on behalf of aSwiss study group Abstract longed treatment with high doses of inhaled Background —Ther